¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"horizontal cell"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
antigen-recognizing cell
Ç׿øÀÎÁö¼¼Æ÷
argentaffin cell
ÀºÄ£È¼¼Æ÷
argyrophilic cell
ÀºÄ£È¼¼Æ÷
asexual cell
¹«¼º¼¼Æ÷
acidophilic cell
È£»ê¼¼Æ÷
acinar cell
»ù²Ê¸®¼¼Æ÷, ¼¼¿±¼¼Æ÷
acinar cell carcinoma
»ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
acinic cell carcinoma
»ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
adult T-cell leukemia/lymphoma
¼ºÀÎT¼¼Æ÷¹éÇ÷º´/¸²ÇÁÁ¾
amacrine cell
¹«Ãà»è¼¼Æ÷
ameboid cell
¾Æ¸Þ¹Ù¸ð¾ç¼¼Æ÷
anaplastic large cell lymphoma
¿ªÇü¼ºÅ«¼¼Æ÷¸²ÇÁÁ¾
basal cell
¹Ù´Ú¼¼Æ÷, ±âÀú¼¼Æ÷
basal cell adenoma
¹Ù´Ú¼¼Æ÷»ùÁ¾, ±âÀú¼¼Æ÷¼±Á¾
basal cell carcinoma
¹Ù´Ú¼¼Æ÷¾ÏÁ¾, ±âÀú¼¼Æ÷¾ÏÁ¾
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
plasma cell
ÇüÁú¼¼Æ÷
polynucleated cell
¹µÇÙ¼¼Æ÷
prickle cell
°¡½Ã¼¼Æ÷
principal cell
ÁÖ¼¼Æ÷, À¸¶ä¼¼Æ÷
Purkinje cell
1. ½ÉÀåÀüµµ±ÙÀ°¼¼Æ÷, 2. Á¶·Õ¹Ú¼¼Æ÷
pyramidal cell
ÇǶó¹Ìµå¼¼Æ÷
red blood cell
ÀûÇ÷±¸
reserve cell
¿¹ºñ¼¼Æ÷
resting cell
ÈÞÁö±â¼¼Æ÷, Á¤Áö¼¼Æ÷
reticuloendothelial cell
±×¹°³»ÇǼ¼Æ÷, ¼¼¸Á³»ÇǼ¼Æ÷
rod cell
¸·´ë¼¼Æ÷
round cell
¿øÇü¼¼Æ÷
satellite cell
À§¼º¼¼Æ÷
scavenger cell
û¼Ò¼¼Æ÷
Schwann's cell
½Å°æÁý¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
antibody-producing cell
Ç×ü»ý»ê¼¼Æ÷
antibody-screening cell
Ç×ü¼±º°Ç÷±¸
antigen-presenting cell
Ç׿øÀü´Þ¼¼Æ÷
antigen-reactive cell
Ç׿ø¹ÝÀÀ¼¼Æ÷
antigen-recognizing cell
Ç׿øÀÎÁö¼¼Æ÷
argentaffin cell
ģũ·ÒÀº¼¼Æ÷
argyrophilic cell
ÀºÄ£È¼¼Æ÷
asexual cell
¹«¼º¼¼Æ÷
basal cell adenoma
±âÀú¼¼Æ÷»ùÁ¾, ¹Ù´Ú¼¼Æ÷¾ÏÁ¾
basosqumaous cell acanthoma
±âÀúÆíÆò¼¼Æ÷°¡½Ã¼¼Æ÷Á¾
cell-associated antibody
¼¼Æ÷ºÎÂøÇ×ü
cell-bound antibody
(¢¡cell-fixed antibody) ¼¼Æ÷°áÇÕÇ×ü
cell-fixed antibody
¼¼Æ÷°áÇÕÇ×ü
clear cell acanthoma
Åõ¸í¼¼Æ÷°¡½Ã¼¼Æ÷Á¾
clear cell adenocarcinoma
Åõ¸í¼¼Æ÷»ù¾ÏÁ¾
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
B cell
B ¼¼Æ÷.
B cell antigen
B ¼¼Æ÷Ç׿ø
B cell differentiation factor (BCDF)
B¼¼Æ÷ ºÐÈÀ¯¹ßÀÎÀÚ
B cell growth factor
B ¼¼Æ÷¼ºÀåÀÎÀÚ
B cell growth factor (BCGF)
B¼¼Æ÷ Áõ½ÄÃËÁøÀÎÀÚ
B cell hybridoma
B¼¼Æ÷ ÇÏÀ̺긮µµ¸¶
B cell lymphoma
B¼¼Æ÷¸²ÇÁÁ¾
B cell stimulating factor (BSF)
B¼¼Æ÷ ÀÚ±ØÀÎÀÚ
B cell study
B ¼¼Æ÷°Ë»ç
B cell/lymphocyte
B ¼¼Æ÷/¸²ÇÁ±¸
B-cell
ºñ ¼¼Æ÷
C-cell
C ¼¼Æ÷
CD4+ cell
CD4+ ¼¼Æ÷
Cell adhesion molecules
¼¼Æ÷À¯ÂøºÐÀÚ
Chinese hamster ovary tumor cell
Áß±¹ÇÔ½ºÅÍ ³¼Ò¼¼Æ÷, CHO¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
horizontal semicirular canal
¼öÆò¹Ý±Ô°ü
horizontal semicirular canal
¼öÆò¹Ý±Ô°ü.
horizontal strabismus
¼öÆò»ç½Ã(â©øÁÞØãÊ).
horizontal transmission
¼öÆòÀüÆÄ
nystagmus, horizontal
¼öÆò¾ÈÁø
alpha cell glucagon cell
¾ËÆÄ¼¼Æ÷ ±Û·çÄ«°ï¼¼Æ÷
beta cell insulin cell
º£Å¸¼¼Æ÷ Àν´¸°¼¼Æ÷
bronchiolar cell clara cell
¼¼±â°üÁö¼¼Æ÷
cell to cell cooperation
¼¼Æ÷°£ÇùÁ¶ÀÛ¿ë(á¬øàÊàúððàíÂéÄ).
chief cell type i glomus cell
°ú¸³¼¼Æ÷
clear cell basal cell carcinoma
Åõ¸í¼¼Æ÷ ±âÀú¼¼Æ÷¾Ï
clear cell epinephrine cell
¹àÀº¼¼Æ÷ ¿¡Çdz×ÇÁ¸°¼¼Æ÷
cytotoxic T-cell ; killer T-cell
(¼¼Æ÷)»ì(ÇØ) T¼¼Æ÷.
dark cell norepinephrine cell
¾îµÎ¿î¼¼Æ÷ ³ë¸£¿¡Çdz×ÇÁ¸°¼¼Æ÷
interstitial cell dark cell
»çÀÌÁú¼¼Æ÷
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½